Related references
Note: Only part of the references are listed.The relationship between B-cell lymphoma 2, interleukin-1β, interleukin-17, and interleukin-33 and the development of diabetic nephropathy
Basant Mahmoud et al.
MOLECULAR BIOLOGY REPORTS (2022)
Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cells
Donghee Kim et al.
JOURNAL OF BIOMEDICAL SCIENCE (2022)
VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses
Yilan Shen et al.
ACTA PHARMACEUTICA SINICA B (2021)
Targeting HDAC6 attenuates nicotine-induced macrophage pyroptosis via NF-κB/NLRP3 pathway
Shuang Xu et al.
ATHEROSCLEROSIS (2021)
Interleukin-22 regulating Kupffer cell polarization through STAT3/Erk/Akt crosstalk pathways to extenuate liver fibrosis
Si-Biao Su et al.
LIFE SCIENCES (2021)
NLRP3 inflammasome in cancer and metabolic diseases
Bhesh Raj Sharma et al.
NATURE IMMUNOLOGY (2021)
A Novel Bifunctional Fusion Protein, Vunakizumab-IL22, for Protection Against Pulmonary Immune Injury Caused by Influenza Virus
Lei Han et al.
FRONTIERS IN IMMUNOLOGY (2021)
Epigenetic regulation of TXNIP-mediated oxidative stress and NLRP3 inflammasome activation contributes to SAHH inhibition-aggravated diabetic nephropathy
Xin Dai et al.
REDOX BIOLOGY (2021)
Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury
Lin-Li Lv et al.
CELL DEATH AND DIFFERENTIATION (2020)
Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice
Xiaogang Xiang et al.
JOURNAL OF HEPATOLOGY (2020)
Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy
Xu-shun Jiang et al.
CELL DEATH & DISEASE (2020)
N-GSDMD trafficking to neutrophil organelles facilitates IL-1β release independently of plasma membrane pores and pyroptosis
Mausita Karmakar et al.
NATURE COMMUNICATIONS (2020)
Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice
Jing Ye et al.
REDOX BIOLOGY (2020)
Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy
Carolina Lavoz et al.
KIDNEY INTERNATIONAL (2019)
Interleukin 17A promotes diabetic kidney injury
Jin Ma et al.
SCIENTIFIC REPORTS (2019)
Mitochondrial dysfunction in diabetic kidney disease
Pascal Zhongping Wei et al.
CLINICA CHIMICA ACTA (2019)
NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-κB signaling
Xueliang Chen et al.
CELL DEATH & DISEASE (2019)
Mitochondrial ROS promote macrophage pyroptosis by inducing GSDMD oxidation
Yufang Wang et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
The Global Epidemiology of Diabetes and Kidney Disease
Digsu N. Koye et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2018)
Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome
Ding Tao et al.
PHYTOMEDICINE (2018)
T helper type 17 cells in immune-mediated glomerular disease
Christian F. Krebs et al.
NATURE REVIEWS NEPHROLOGY (2017)
Paradoxical Role of IL-17 in Progression of Diabetic Nephropathy
Daniel L. Galvan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis
Riyaz Mohamed et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Innate immunity in diabetes and diabetic nephropathy
Jun Wada et al.
NATURE REVIEWS NEPHROLOGY (2016)
Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes
Melinda T. Coughlan et al.
CLINICAL SCIENCE (2016)
Caspase-1, but Not Caspase-3, Promotes Diabetic Nephropathy
Khurrum Shahzad et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy
Yuan-ye Qiu et al.
PHARMACOLOGICAL RESEARCH (2016)
IL-17 in Chronic Inflammation: From Discovery to Targeting
Audrey Beringer et al.
TRENDS IN MOLECULAR MEDICINE (2016)
ROR Inverse Agonist Suppresses Insulitis and Prevents Hyperglycemia in a Mouse Model of Type 1 Diabetes
Laura A. Solt et al.
ENDOCRINOLOGY (2015)
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Jianjin Shi et al.
NATURE (2015)
Pathophysiology of T follicular helper cells in humans and mice
Hideki Ueno et al.
NATURE IMMUNOLOGY (2015)
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
Philip J. Mease et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Vitamin D Prevents Podocyte Injury via Regulation of Macrophage M1/M2 Phenotype in Diabetic Nephropathy Rats
Xiao-Liang Zhang et al.
ENDOCRINOLOGY (2014)
Therapeutic opportunities of the IL-22-IL-22R1 system
Robert Sabat et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer
Jan C. Dudda et al.
IMMUNITY (2013)
MECHANISMS OF DIABETIC COMPLICATIONS
Josephine M. Forbes et al.
PHYSIOLOGICAL REVIEWS (2013)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A
Gregory F. Sonnenberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Macrophages and Diabetic Nephropathy
Greg H. Tesch
SEMINARS IN NEPHROLOGY (2010)
Mouse Models of Diabetic Nephropathy
Frank C. Brosius et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Share Paper
